UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhibition of p38α MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-XL, Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo

Leukemia, 2006-06, Vol.20 (6), p.1017-1027

2006

Volltextzugriff (PDF)

Oral anti-inflammatory action of NPC 18884, a novel bradykinin B2 receptor antagonist

European journal of pharmacology, 1998-12, Vol.363 (2-3), p.179-187

1998

Volltextzugriff (PDF)

Oral antinociception and oedema inhibition produced by NPC 18884, a non-peptidic bradykinin B2 receptor antagonist

Naunyn-Schmiedeberg's archives of pharmacology, 1999-09, Vol.360 (3), p.278-286

1999

Volltextzugriff (PDF)

New ring systems from 1,2-benzisothiazole-1,1-dioxides and related compounds

Tetrahedron, 1996-02, Vol.52 (9), p.3339-3354

1996

Volltextzugriff (PDF)

Synthesis and Characterization of Pseudopeptide Bradykinin B2 Receptor Antagonists Containing the 1,3,8-Triazaspiro[4.5]decan-4-one Ring System

Journal of medicinal chemistry, 1996-08, Vol.39 (16), p.3169-3173

1996

Volltextzugriff (PDF)

Pharmacologic profile of NPC 168 (naltrexone phenyl oxime), a novel compound with activity at opioid receptors

Pharmacology, biochemistry and behavior, 1990-11, Vol.37 (3), p.497-504

1990

Volltextzugriff (PDF)

Opioid agonist properties of two oxime derivatives of naltrexone, NPC 831 and NPC 836

Pharmacology, biochemistry and behavior, 1993, Vol.44 (1), p.45-50

1993

Volltextzugriff (PDF)

Novel bradykinin receptor antagonists from a structurally directed non-peptide combinatorial library

Immunopharmacology, 1996-06, Vol.33 (1-3), p.61-67

1996

Volltextzugriff (PDF)

A Combinatorial Approach to the Identification of Dipeptide Aldehyde Inhibitors of β-Amyloid Production

Journal of medicinal chemistry, 1999-09, Vol.42 (19), p.3889-3898

1999

Volltextzugriff (PDF)

Preparation of 2-aryl and 2-aryloxymethyl imidazo[1,2-a]pyridines and related compounds

Journal of heterocyclic chemistry, 1988-01, Vol.25 (1), p.129-137

1988

Volltextzugriff (PDF)

Inhibition of p38 alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X sub(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo

Leukemia, 2006-06, Vol.20 (6), p.1017-1027

2006

Volltextzugriff (PDF)

Antioedematogenic and antinociceptive actions of NPC 18521, a novel bradykinin B2 receptor antagonist

European journal of pharmacology, 1996-12, Vol.316 (2-3), p.277-286

1996

Volltextzugriff (PDF)

Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo

Leukemia, 2006-06, Vol.20 (6), p.1017-1027

2006

Volltextzugriff (PDF)

Inhibition of p38[alpha] MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-XL, Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo

Leukemia, 2006-06, Vol.20 (6), p.1017

2006

Volltextzugriff (PDF)

Cationic antiprotozoal drugs. Trypanocidal activity of 2-(4'-formylphenyl)imidazo[1,2-a]pyridinium guanylhydrazones and related derivatives of quaternary heteroaromatic compounds

Journal of medicinal chemistry, 1990-01, Vol.33 (1), p.298-307

1990

Volltextzugriff (PDF)

Inhibition of p38α MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-XK, Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo

Leukemia, 2006, Vol.20 (6), p.1017-1027

2006

Volltextzugriff (PDF)

Indole-based heterocyclic inhibitors of p38α MAP kinase: designing a conformationally restricted analogue

Bioorganic & medicinal chemistry letters, 2003, Vol.13 (18), p.3087-3090

2003

Volltextzugriff (PDF)

Synthesis and opioid activities of some naltrexone oxime ethers

European journal of medicinal chemistry, 1994, Vol.29 (9), p.659-666

1994

Volltextzugriff (PDF)

Antioedematogenic and antinociceptive actions of NPC 18521, a novel bradykinin B 2 receptor antagonist

European journal of pharmacology, 1996-12, Vol.316 (2), p.277-286

1996

Volltextzugriff (PDF)

Asymmetric synthesis of (R)-and (S)- enantiomers of novel phenylalanine homologues

Tetrahedron letters, 1993-04, Vol.34 (14), p.2255-2258

1993

Volltextzugriff (PDF)

Oral anti-inflammatory action of NPC 18884, a novel bradykinin B 2 receptor antagonist

European journal of pharmacology, 1998-12, Vol.363 (2), p.179-187

1998

Volltextzugriff (PDF)

Solid phase synthesis of combinatorial libraries using anhydrides as templates

Molecular diversity, 1997, Vol.3 (2), p.121-128

1997

Volltextzugriff (PDF)

ChemInform Abstract: Asymmetric Synthesis of (R)- and (S)-Enantiomers of Novel Phenylalanine Homologues

ChemInform, 1993-09, Vol.24 (37), p.no-no

1993

Volltextzugriff (PDF)

ChemInform Abstract: 1,2‐BENZISOTHIAZOLE 1,1‐DIOXIDE: A CONVENIENT SYNTHESIS. THE QUESTION OF THE POSSIBLE AROMATICITY OF 1,2‐BENZOTHIAZEPINE 1,1‐DIOXIDES

Chemischer Informationsdienst, 1983-09, Vol.14 (36)

1983

Volltextzugriff (PDF)

ChemInform Abstract: New Ring Systems from 1,2-Benzisothiazole-1,1-dioxides and Related Compounds

ChemInform, 1996-06, Vol.27 (25), p.no-no

1996

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhibition of p38α MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-XL, Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo

Oral anti-inflammatory action of NPC 18884, a novel bradykinin B2 receptor antagonist

Oral antinociception and oedema inhibition produced by NPC 18884, a non-peptidic bradykinin B2 receptor antagonist

New ring systems from 1,2-benzisothiazole-1,1-dioxides and related compounds

Synthesis and Characterization of Pseudopeptide Bradykinin B2 Receptor Antagonists Containing the 1,3,8-Triazaspiro[4.5]decan-4-one Ring System

Pharmacologic profile of NPC 168 (naltrexone phenyl oxime), a novel compound with activity at opioid receptors

Opioid agonist properties of two oxime derivatives of naltrexone, NPC 831 and NPC 836

Novel bradykinin receptor antagonists from a structurally directed non-peptide combinatorial library

A Combinatorial Approach to the Identification of Dipeptide Aldehyde Inhibitors of β-Amyloid Production

Preparation of 2-aryl and 2-aryloxymethyl imidazo[1,2-a]pyridines and related compounds

Inhibition of p38 alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X sub(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo

Antioedematogenic and antinociceptive actions of NPC 18521, a novel bradykinin B2 receptor antagonist

Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo

Inhibition of p38[alpha] MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-XL, Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo

Cationic antiprotozoal drugs. Trypanocidal activity of 2-(4'-formylphenyl)imidazo[1,2-a]pyridinium guanylhydrazones and related derivatives of quaternary heteroaromatic compounds

Inhibition of p38α MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-XK, Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo

Indole-based heterocyclic inhibitors of p38α MAP kinase: designing a conformationally restricted analogue

Synthesis and opioid activities of some naltrexone oxime ethers

Antioedematogenic and antinociceptive actions of NPC 18521, a novel bradykinin B 2 receptor antagonist

Asymmetric synthesis of (R)-and (S)- enantiomers of novel phenylalanine homologues

Oral anti-inflammatory action of NPC 18884, a novel bradykinin B 2 receptor antagonist

Solid phase synthesis of combinatorial libraries using anhydrides as templates

ChemInform Abstract: Asymmetric Synthesis of (R)- and (S)-Enantiomers of Novel Phenylalanine Homologues

ChemInform Abstract: 1,2‐BENZISOTHIAZOLE 1,1‐DIOXIDE: A CONVENIENT SYNTHESIS. THE QUESTION OF THE POSSIBLE AROMATICITY OF 1,2‐BENZOTHIAZEPINE 1,1‐DIOXIDES

ChemInform Abstract: New Ring Systems from 1,2-Benzisothiazole-1,1-dioxides and Related Compounds

Suchergebnisse filtern